Articles

• Open Access

  Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles

  Belén de la Hera, Elena Urcelay, David Brassat, Andrew Chan, Angela Vidal-Jordana, Anke Salmen, Luisa Maria Villar, José Carlos Álvarez-Cermeño, Guillermo Izquierdo, Oscar Fernández, Begoña Oliver, Albert Saiz, Jose Ramón Ara, Ana G. Vigo, Rafael Arroyo, Virginia Meca, Sunny Malhotra, Nicolás Fissolo, Alejandro Horga, Xavier Montalban, Manuel Comabella

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis

  Sudarshini Ramanathan, Stephen W. Reddel, Andrew Henderson, John D.E. Parratt, Michael Barnett, Prudence N. Gatt, Vera Merheb, Raani-Yogeeta Anusuiya Kumaran, Karrnan Pathmanandavel, Nese Sinmaz, Mahtab Ghadiri, Con Yiannikas, Steve Vucic, Graeme Stewart, Andrew F. Bleasel, David Booth, Victor S.C. Fung, Russell C. Dale, Fabienne Brilot

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Leucine-rich glioma-inactivated protein 1 antibody encephalitisA case report

  Yunis Mayasi, Deepak Takhtani, Neeta Garg

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Rituximab as a first-line preventive treatment in pediatric NMOSDsPreliminary results in 5 children

  Giulia Longoni, Brenda Banwell, Massimo Filippi, E. Ann Yeh

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis

  Francesco Mori, Concetta Ljoka, Carolina G. Nicoletti, Hajime Kusayanagi, Fabio Buttari, Laura Giordani, Silvia Rossi, Calogero Foti, Diego Centonze

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Occurrence of hemolytic anemia in patients with GBS treated with high-dose IVIg

  Thy P. Nguyen, Suur Biliciler, Amer Wahed, Kazim Sheikh

  • Abstract
  • Full Text
  • Full Text (PDF)